Targeted Therapies In Cancer: Myth Or Reality?-..
R$ 1.410,92
até
4x
de
R$ 352,73
sem juros
ou R$ 1.340,37
via Pix
Adicionar ao carrinho
Disponibilidade: 45 dias úteis
Estoque: 161 unidades
-
- 1x de R$ 1.410,92 sem juros
- 2x de R$ 705,46 sem juros
- 3x de R$ 470,30 sem juros
- 4x de R$ 352,73 sem juros
-
R$ 1.340,37
-
R$ 1.410,92
Every cancer research scientist will need a copy of this text. As billions of dollars are spent every year on research into targeted therapies for cancer, it's more than ever crucial for the thousands of scientists working in the field to keep right up to date with the cutting edge. This fascinating collection of material goes a long way to helping them do so, featuring as it does contributions to a crucial international meeting in Italy. The meeting provided a forum for scientists and clinicians working in cancer drug discovery and therapy to share their opinions and experiences on the paradigm shift from empiricism to molecular targeted therapies and its effect on the development of new cancer therapies. The text here offers readers an overview of diverse approaches, ranging from drug discovery to cellular therapy. Overall, the book addresses the key question of whether ultimately targeted therapy in cancer will be a myth or a reality.
| ISBN | 9780387738970 |
| Autor(a) | Colotta, Francesco |
| Editora | Springer Publishing |
| Ano de edição | 2007 |
| Páginas | 191 |
| Acabamento | Capa Dura |
Produtos relacionados
-
Targeted Therapies In Cancer:: Myth Or Reality?-..R$ 1.410,92até 4x de R$ 352,73 sem jurosou R$ 1.340,37 via Pix -
Targeted Therapies In Cancer-..
R$ 1.410,92R$ 1.128,74até 4x de R$ 282,18 sem jurosou R$ 1.072,30 via Pix20% Desconto -
Targeted Therapies In Cancer-..
R$ 995,92R$ 796,74até 4x de R$ 199,18 sem jurosou R$ 756,90 via Pix20% Desconto -
Targeted Therapies For Lung Cancer-..R$ 1.161,92até 4x de R$ 290,48 sem jurosou R$ 1.103,82 via Pix
-
Categorias
Pague com
Selos
MYRE EDITORA, COMERCIALIZADORA, IMPORTADORA E DISTRIBUIDORA LTDA - CNPJ: 50.295.718/0001-20 © Todos os direitos reservados. 2026
